Alnylam Pharmaceuticals (ALNY) Interest Coverage Ratio (2020 - 2026)
Alnylam Pharmaceuticals posted quarterly Interest Coverage Ratio of 3.88 for Q1 2026, up 1150.63% year-on-year from 0.31 in Q1 2025, and up 92.51% on a QoQ basis from 2.01 in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 7 years of Interest Coverage Ratio data on file, last reported at 3.88 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 1150.63% year-over-year to 3.88; the trailing twelve-month figure through Mar 2026 stood at 3.43 (up 590.18% YoY), and the FY2025 full-year result was 1.99, up 259.23% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 3.88, up from 2.01 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 8.29 in Q3 2025 and bottomed at 7.65 in Q2 2023.
- The 5-year median for Interest Coverage Ratio is 2.24 (2024), against an average of 1.22.
- The widest annual swing landed in 2024, when Interest Coverage Ratio tumbled 132.32%; it then surged 1150.63% in 2026.
- A 5-year view of Interest Coverage Ratio shows it stood at 6.31 in 2022, then jumped by 41.09% to 3.71 in 2023, then increased by 27.35% to 2.7 in 2024, then jumped by 174.64% to 2.01 in 2025, then surged by 92.51% to 3.88 in 2026.
- The last three Interest Coverage Ratio figures came in at 3.88 (Q1 2026), 2.01 (Q4 2025), and 8.29 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | -36.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.88 |
| Dec 31, 2025 | 2.01 |
| Sep 30, 2025 | 8.29 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | -2.70 |
| Sep 30, 2024 | -2.24 |
| Jun 30, 2024 | 1.46 |
| Mar 31, 2024 | -1.23 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | 6.92 |
| Jun 30, 2023 | -7.65 |
| Mar 31, 2023 | -5.17 |
| Dec 31, 2022 | -6.31 |
| Sep 30, 2022 | -6.28 |
| Jun 30, 2022 | -4.50 |
| Mar 31, 2022 | -3.46 |
| Dec 31, 2021 | -5.28 |
| Sep 30, 2021 | -4.51 |
| Jun 30, 2021 | -4.37 |
| Mar 31, 2021 | -5.73 |
| Dec 31, 2020 | -6.81 |
| Sep 30, 2020 | -7.84 |
| Jun 30, 2020 | -7.30 |